A Transgenic Approach To Rationale Drug Design In Plasmodium Falciparum
Funder
National Health and Medical Research Council
Funding Amount
$420,872.00
Summary
Malaria is a disease caused by parasites of the genus Plasmodium. It is responsible for more than 2 million deaths per year predominately in Sub-Saharan Africa. Many of the currently used drugs to combat this disease are failing through drug resistance in the parasite population. New and novel drugs are urgently required. This project uses state of the art techniques to identify and validate new and novel targets within the parasite that can be used for rational drug design
This research will elucidate pathways in the brain that control satiety, in particular the role of neuropeptide Y and the satiety hormones peptide YY and pancreatic polypeptide. By understanding how satiety is controlled, this process could be stimulated for potential use as a novel treatment strategy for obesity or anorexia.